Autoimmune hemolytic anemia (AIHA) is a relatively uncommon disorder caused by
autoantibodies directed against self red blood cells. It can be idiopathic or secondary, and …

Evans' syndrome (ES) is defined as the concomitant or sequential association of warm auto-
immune haemolytic anaemia (AIHA) with immune thrombocytopenia (ITP), and less …

Evans syndrome (ES) is a rare disease characterized by the simultaneous or sequential
development of autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP) …

Evans syndrome (ES) is a rare and chronic autoimmune disease characterized by
autoimmune hemolytic anemia and immune thrombocytopenic purpura with a positive direct …

Background Autoimmune haemolytic anaemia is a decompensated acquired haemolysis
caused by the host's immune system acting against its own red cell antigens. The incidence …

Rituximab (RTX) is a monoclonal antibody against CD20, commonly used in the treatment of
hematological malignancies and autoimmune diseases. The use of RTX is related to the …

Summary The management of Evans Syndrome in children is challenging due to the lack of
evidence‐based data on treatment. Steroids, the first‐choice therapy, are successful in …

The treatment of both auto‐immune haemolytic anaemia (AIHA) and auto‐immune
thromobocytopenic purpura (AITP) remains unsatisfactory in those refractory to first‐line …

Background Rituximab has been widely used off-label as a second line treatment for
children with immune thrombocytopenia (ITP). However, its role in the management of …

Diagnosis and Management of Autoimmune Cytopenias in Childhood - Pediatric Clinics Skip
to Main Content Pediatric Clinics Log in Register Log in Subscribe Claim Skip menu …